DAXXIFY (daxibotulinumtoxinA-lanm) or “DAXI” is an injectable neurotoxin that is FDA-approved to treat glabellar lines (the frown lines between the eyebrows—commonly referred to as the “11s”). 

What makes DAXXIFY different from its competitors is its unique formulation; the toxin that temporarily blocks the signals to the muscle is attached to a protein—helping to extend DAXXIFY’s effects on treated muscles. In fact, clinical trials found that DAXXIFY results can last between 6-9 months, potentially lasting 2-3 times longer than BOTOX for some patients.

Additionally, DAXXIFY is the first injectable neurotoxin formulated using a novel peptide as a stabilizer, meaning it does not contain human or animal byproducts.